MedPath

Exercise Training and Endothelial Function in Type 1 Diabetes

Not Applicable
Recruiting
Conditions
Type1diabetes
Interventions
Behavioral: Exercise Training Procedure
Behavioral: Normal life procedure
Registration Number
NCT03528226
Lead Sponsor
University Hospital, Lille
Brief Summary

Endothelial dysfunction and vasoreactivity disorders are early subclinical complications of type 1 diabetes (T1D). In a preventive setting, in T1D patients still free of complications, the research of non-pharmacological interventions to improve endothelial function appears fundamental.

In this randomized controlled trial, the effects of exercise training on endothelial function will be evaluated in T1D adults. Secondary objectives are to evaluate the exercise training effects on the micro and macrovascular function and exercise-induced tissue vasoreactivity and their possible neurometabolic consequences.

An improvement in vascular function, particularly endothelium-dependent, as well as in neurometabolic profile, through this non-pharmacological strategy is expected

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Covered by social security
  • With a T1Diabete, diagnosed for at least 1 year, and free from macrovascular and microvascular diabetic complications.
Exclusion Criteria
  • type 1 diabetes diagnoses for less than 1 year
  • MODY diabetes, mitochondrial diabetes or type 2 diabetes
  • presence of macrovascular and/or microvascular diabetic complications (retinopathy, nephropathy, neuropathy ,...)
  • Obesity (Body Mass Index > 30 kg/m²
  • Smokers
  • Hypertension
  • Disabling painful discomfort for trunk, upper or lower limb movements
  • Active chronic disease or in remission (excluding type 1 diabetes)
  • Head trauma in the past

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Exercise TrainingExercise Training Procedure-
ControlNormal life procedure-
Primary Outcome Measures
NameTimeMethod
Change in percent flow-mediated dilation (FMD) valuesbetween baseline and at 4 months
Secondary Outcome Measures
NameTimeMethod
Change in percent flow-mediated dilation (FMD) valuesbetween baseline and at 2 months
Change Blood marker concentrations of nitric oxide (NO)at baseline , at 2 months , at 4 months
Change the vascular responsesat baseline , at 2 months , at 4 months

Endothelium-dependent vasodilation capacity induced by post-occlusive reactive hyperaemia (5min occlusion) at the level of microcirculation (skin capillaries and arterioles of the hand)

-Evolution of the blood volume at the vastus lateralis muscle and the prefrontal cortex in response to an incremental maximal exercise

Body composition (DEXA)at baseline , at 2 months , at 4 months
change the maximum oxygen consumption ( VO2max)at baseline , at 2 months , at 4 months
change Blood concentration of neurotrophic factorsat baseline , at 2 months , at 4 months

Blood concentration of neurotrophic factors and blood markers of metabolic profile

Trial Locations

Locations (1)

Hop Claude Huriez Chu Lille

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath